Nicotine Replacement Therapy (NRT) Market Size, Share & Industry Analysis
商品番号 : SMB-80762
出版社 | Fortune Business Insights |
出版年月 | 2025年6月 |
ページ数 | 160 |
価格タイプ | シングルユーザライセンス |
価格 | USD 4,850 |
種別 | 英文調査報告書 |
ニコチン置換療法(NRT)市場 : 種類(ガム、パッチ、ロゼンジ、吸入器など)、流通チャネル別(病院・薬局、小売店、オンラインチャネル)、地域別の市場規模、シェア、業界分析および予測 2025-2032年
Growth Factors of Nicotine Replacement Therapy (NRT) Market
The global nicotine replacement therapy (NRT) market was valued at USD 3.23 billion in 2023 and is projected to grow from USD 3.38 billion in 2024 to USD 5.23 billion by 2032, according to Fortune Business Insights. This reflects a compound annual growth rate (CAGR) of 5.6% during the forecast period. The market is driven by rising awareness of the health risks of tobacco, increasing government initiatives, and the growing availability of over-the-counter (OTC) NRT products.
世界のニコチン置換療法(NRT)市場は2023年に32億3,000万米ドルと評価され、2024年の33億8,000万米ドルから2032年には52億3,000万米ドルに成長すると予測されています。これは、予測期間中の年平均成長率(CAGR)5.6%を反映しています。この市場は、タバコの健康リスクに対する意識の高まり、政府の取り組みの強化、そして市販薬(OTC)NRT製品の入手しやすさの向上によって牽引されています。

What is Nicotine Replacement Therapy?
Nicotine Replacement Therapy (NRT) involves the medically approved use of products that supply low doses of nicotine to help people quit smoking. These products reduce withdrawal symptoms and cravings, making the transition to a smoke-free life more manageable. Common NRT products include nicotine patches, gums, lozenges, nasal sprays, inhalers, and tablets.
NRT has been endorsed by global health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) as an effective smoking cessation tool. As smoking remains a leading cause of preventable diseases, the demand for safer and scientifically backed cessation tools is rising.
Market Drivers
- Increasing Health Awareness: Growing public consciousness about the health risks of smoking—including cancer, respiratory disorders, and cardiovascular diseases—is one of the major drivers of NRT product demand. Consumers are actively seeking alternatives to help quit smoking, and NRTs are considered a proven, safe method.
- Government and NGO Support: Public health campaigns, anti-smoking regulations, and cessation programs led by governments and non-profit organizations are boosting NRT adoption. Many countries have included NRT products in subsidized healthcare programs or national quit-smoking initiatives.
- Rising Smoking Cessation Rates: Countries such as the U.S., UK, and Australia have witnessed a significant reduction in smoking prevalence due to aggressive health policies. The accessibility of NRTs in pharmacies, online platforms, and clinics has made quitting more approachable for the masses.
- Innovation in Product Forms: Modern NRT products are evolving to improve user experience. For example, oral sprays and flavored gums provide quicker nicotine delivery and better taste, helping maintain user compliance and satisfaction.
Market Segmentation Insights
The NRT market is segmented based on product type, including gum, patches, lozenges, inhalers, and nasal sprays. Among these, nicotine gum and patches hold the largest market shares, owing to their widespread availability, cost-effectiveness, and proven efficacy.
From a distribution channel perspective, pharmacies dominate the landscape, followed by online platforms which have gained momentum, especially post-COVID-19, due to their convenience and privacy.
Regional Analysis
North America is the largest regional market, led by the U.S., where strong public health initiatives, high healthcare awareness, and wide availability of NRT products contribute to dominant market share. Government-run helplines and insurance coverage for cessation therapy also aid market penetration.
Europe follows closely, with the UK, Germany, and France being major contributors. The UK’s National Health Service (NHS) actively promotes NRT through cessation clinics and GP consultations.
Asia Pacific is projected to experience the fastest growth during the forecast period. Rapid urbanization, growing health literacy, and high smoking rates in countries like China, India, and Indonesia make this region a key target for NRT companies. However, cultural attitudes toward smoking cessation and limited access to healthcare services may restrain faster adoption.
Leading Market Players
Several companies are actively competing in the global NRT market through product innovation, expansion into emerging markets, and strategic partnerships. Major players include:
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc
- Perrigo Company plc
- Cipla Inc.
- Dr. Reddy’s Laboratories
- Reynolds American Inc.
- Alchem International
- Pierre Fabre Group
- British American Tobacco
- Takeda Pharmaceuticals
These companies offer a wide range of NRT products and are increasingly focused on user-friendly formats, such as quick-acting oral sprays and sugar-free gums.
Conclusion
With growing global efforts to combat smoking and tobacco addiction, the Nicotine Replacement Therapy market is poised for steady growth. As regulations tighten and public awareness increases, NRT products offer a practical and effective solution for millions seeking to quit smoking. With the market projected to surpass USD 5.23 billion by 2032, the future of NRT appears promising in supporting a tobacco-free world.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Estimated Year 2025
Forecast Period 2025-2032
Historical Period 2019-2023
Unit Value (USD Billion)
Growth Rate CAGR of 4.8% from 2025-2032
Segmentation
By Type
- Gums
- Patches
- Lozenges
- Inhalers
- Others
By Distribution Channel
- Hospitals & Retail Pharmacies
- Retail Stores
- Online Channels
By Region
- North America (By Type, Distribution Channel, and Country)
o U.S. (By Type)
o Canada (By Type)
- Europe (By Type, Distribution Channel, and Country/Sub-region)
o U.K. (By Type)
o Germany (By Type)
o France (By Type)
o Spain (By Type)
o Italy (By Type)
o Scandinavia (By Type)
o Rest of Europe (By Type)
- Asia Pacific (By Type, Distribution Channel, and Country/Sub-region)
o Japan (By Type)
o China (By Type)
o India (By Type)
o Australia (By Type)
o Southeast Asia (By Type)
o Rest of the Asia Pacific (By Type)
- Latin America (By Type, Distribution Channel, and Country/Sub-region)
o Brazil (By Type)
o Mexico (By Type)
o Rest of Latin America (By Type)
- Middle East & Africa (By Type, Distribution Channel, and Country/Sub-region)
o GCC
o South Africa
o Rest of the Middle East & Africa (By Type)
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Number of Smokers – by Countries/Sub-region, 2024/2024
4.2. New Product Launches
4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
4.4. Impact of COVID-19 on the Market
5. Global Nicotine Replacement Therapy (NRT) Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Gums
5.1.2. Patches
5.1.3. Lozenges
5.1.4. Inhalers
5.1.5. Others
5.2. Market Analysis, Insights and Forecast – By Distribution Channel
5.2.1. Hospital & Retail Pharmacies
5.2.2. Retail Stores
5.2.3. Online Channels
5.3. Market Analysis, Insights and Forecast – By Geography
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. Latin America
5.3.5. Middle East & Africa
6. North America Nicotine Replacement Therapy (NRT) Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Gums
6.1.2. Patches
6.1.3. Lozenges
6.1.4. Inhalers
6.1.5. Others
6.2. Market Analysis, Insights and Forecast – By Distribution Channel
6.2.1. Hospital & Retail Pharmacies
6.2.2. Retail Stores
6.2.3. Online Channels
6.3. Market Analysis, Insights and Forecast – By Country
6.3.1. U.S.
6.3.2. Canada
7. Europe Nicotine Replacement Therapy (NRT) Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Gums
7.1.2. Patches
7.1.3. Lozenges
7.1.4. Inhalers
7.1.5. Others
7.2. Market Analysis, Insights and Forecast – By Distribution Channel
7.2.1. Hospital & Retail Pharmacies
7.2.2. Retail Stores
7.2.3. Online Channels
7.3. Market Analysis, Insights and Forecast – By Country/Sub-region
7.3.1. U.K.
7.3.2. Germany
7.3.3. France
7.3.4. Spain
7.3.5. Italy
7.3.6. Scandinavia
7.3.7. Rest of Europe
8. Asia Pacific Nicotine Replacement Therapy (NRT) Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Gums
8.1.2. Patches
8.1.3. Lozenges
8.1.4. Inhalers
8.1.5. Others
8.2. Market Analysis, Insights and Forecast – By Distribution Channel
8.2.1. Hospital & Retail Pharmacies
8.2.2. Retail Stores
8.2.3. Online Channels
8.3. Market Analysis, Insights and Forecast – By Country/Sub-region
8.3.1. Japan
8.3.2. China
8.3.3. India
8.3.4. Australia
8.3.5. Southeast Asia
8.3.6. Rest of Asia Pacific
9. Latin America Nicotine Replacement Therapy (NRT) Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Gums
9.1.2. Patches
9.1.3. Lozenges
9.1.4. Inhalers
9.1.5. Others
9.2. Market Analysis, Insights and Forecast – By Distribution Channel
9.2.1. Hospital & Retail Pharmacies
9.2.2. Retail Stores
9.2.3. Online Channels
9.3. Market Analysis, Insights and Forecast – By Country/Sub-region
9.3.1. Brazil
9.3.2. Mexico
9.3.3. Rest of Latin America
10. Middle East & Africa Nicotine Replacement Therapy (NRT) Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Gums
10.1.2. Patches
10.1.3. Lozenges
10.1.4. Inhalers
10.1.5. Others
10.2. Market Analysis, Insights and Forecast – By Distribution Channel
10.2.1. Hospital & Retail Pharmacies
10.2.2. Retail Stores
10.2.3. Online Channels
10.3. Market Analysis, Insights and Forecast – By Country/Sub-region
10.3.1. GCC
10.3.2. South Africa
10.3.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2024)
11.2. Company Profiles
11.2.1. Haleon Group of Companies
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Johnson & Johnson Services, Inc.
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Perrigo Company plc
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Pierre Fabre group
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Pfizer, Inc.
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Cipla, Ltd.
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Dr. Reddy’s Laboratories Ltd.
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. ITC Limited
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
Fortune Business Insights(フォーチュンビジネスインサイツ)は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
シングルユーザ | マルチユーザ | エンタープライズ |
USD4,850 | USD5,850 | USD6,850 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 提供ファイル:PDF(印刷不可)
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 提供ファイル:PDF(印刷不可)+Excel(印刷不可)
- 同一企業内6名までレポートファイルのご共有が可能です。
- エンタープライズライセンス
- 提供ファイル:PDF(印刷可能)+Excel(印刷可能)
- 同一企業内人数無制限でレポートファイルのご共有が可能です。
- シングルユーザライセンス
- 納品方法
- Eメール
- 納期
- レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。
最新調査レポート